| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/24/2010 | CN101679277A Novel peptide inhibitors of hepatitis c virus replication |
| 03/24/2010 | CN101679276A Isoquinolinone derivatives as nk3 antagonists |
| 03/24/2010 | CN101679275A New compounds 707 and their uses |
| 03/24/2010 | CN101679274A phthalazine and isoquinoline derivatives with slp receptor modulating activities |
| 03/24/2010 | CN101679273A 1-substituted tetrahydroisoquinoline compound |
| 03/24/2010 | CN101679272A Triazolo [1, 5-a] quinolines as adenosine A3 receptor ligands |
| 03/24/2010 | CN101679271A Quinoline derivatives, pharmaceutical compositions comprising them, and their use in treating central nervous system and peripheral diseases |
| 03/24/2010 | CN101679270A dihydroquinone and dihydronaphthridine inhibitors of jnk |
| 03/24/2010 | CN101679266A PIM kinase inhibitors and methods of their use |
| 03/24/2010 | CN101679265A Salts of isophosphoramide mustard and analogs thereof |
| 03/24/2010 | CN101679264A inhibitors of focal adhesion kinase |
| 03/24/2010 | CN101679263A fluorinated derivatives of deferiprone |
| 03/24/2010 | CN101679262A Pyridone compound |
| 03/24/2010 | CN101679261A Piperazine and piperidine mglur5 potentiators |
| 03/24/2010 | CN101679260A 4,4-disubstituted piperidine derivatives |
| 03/24/2010 | CN101679256A mono-hydrochloric salts of an inhibitor of histone deacetylase |
| 03/24/2010 | CN101679255A Piperidinones useful in the treatment of inflammation |
| 03/24/2010 | CN101679254A Piperidinones useful in the treatment of inflammation |
| 03/24/2010 | CN101679251A (Aza)indole derivative and use thereof for medical purposes |
| 03/24/2010 | CN101679250A Ppar活性化合物 Ppar active compounds |
| 03/24/2010 | CN101679249A Indole and benzothiophene compounds as modulators of the histamine h3 receptor |
| 03/24/2010 | CN101679248A Indole derivative having cpla2 inhibitory activity, use of the same and method for producing the same |
| 03/24/2010 | CN101679246A Novel pyrrolinone derivative and medicinal composition containing the same |
| 03/24/2010 | CN101679244A 5-membered heterocyclic derivative and use thereof for medical purposes |
| 03/24/2010 | CN101679243A atropisomer of pyrrole derivative |
| 03/24/2010 | CN101679241A Prolinamide derivatives as NK3 antagonists |
| 03/24/2010 | CN101679240A p1-nonepimerizable ketoamide inhibitors of hcv ns3 protease |
| 03/24/2010 | CN101679239A inhibitors of histone deacetylase |
| 03/24/2010 | CN101679236A Process for the preparation of ezetimibe and derivatives thereof |
| 03/24/2010 | CN101679235A Azetidine derivatives and their use as prostaglandin E2 antagonists |
| 03/24/2010 | CN101679220A inhibitors of histone deacetylase |
| 03/24/2010 | CN101679217A N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase |
| 03/24/2010 | CN101678215A Sulfonyl amide derivatives for the treatment of abnormal cell growth |
| 03/24/2010 | CN101678214A 芳基醚哒嗪酮衍生物 Aryl ether pyridazinones |
| 03/24/2010 | CN101678212A Pharmaceutical compositions and method for treating acute mania |
| 03/24/2010 | CN101678146A Novel agent for salting out active principles in dressings containing at least one fatty substance |
| 03/24/2010 | CN101678115A Pharmaceutical composition comprising porous dry matrix |
| 03/24/2010 | CN101678114A Solid dosage forms |
| 03/24/2010 | CN101678112A Methods and compositions for the delivery of a therapeutic agent |
| 03/24/2010 | CN101678109A formulations of deacetylase inhibitors |
| 03/24/2010 | CN101678108A Anti-inflammatory compositions comprising tetracyclines and use thereof in therapy |
| 03/24/2010 | CN101678106A Combination of Blys inhibition and/or APRIL inhibition and immunnosuppressants for treatment of autoimmune disease |
| 03/24/2010 | CN101678080A Therapeutic effects of bryostatins, bryologs, and other related substances on ischemia/stroke-induced memory impairment and brain injury |
| 03/24/2010 | CN101678078A SPARC and methods of use thereof |
| 03/24/2010 | CN101678073A Methods and compositions for use of cyclic analogues of histatin |
| 03/24/2010 | CN101678062A Drugs for treating and preventing benign prostatic hyperplasia, prostatitis, impotency, infertility and prostate cancer and a method for the use thereof |
| 03/24/2010 | CN101678057A Method for extracting secoisolariciresinol and dihydroquercetin from wood |
| 03/24/2010 | CN101678053A Method for treating or preventing systemic inflammation |
| 03/24/2010 | CN101678047A Remedy and diagnostic for mitochondrial dysfunction brain disease |
| 03/24/2010 | CN101678046A Stabilized picoplatin oral dosage form |
| 03/24/2010 | CN101678043A Composition for promoting ketone compound formation |
| 03/24/2010 | CN101678042A Suspension for visualization of transparent tissue in eye |
| 03/24/2010 | CN101678041A Bioabsorbable elastomeric polymer networks, cross-linkers and methods of use |
| 03/24/2010 | CN101678040A Use of carrageenan for treating rhinovirus infections |
| 03/24/2010 | CN101678039A Mixture and method for reducing cholesterol using hydrophobic microparticles |
| 03/24/2010 | CN101678038A Device and method for intraocular drug delivery |
| 03/24/2010 | CN101678037A Combined use of cholestanol derivative |
| 03/24/2010 | CN101678036A Novel active ingredient in cicatrization and use thereof |
| 03/24/2010 | CN101678035A selective androgen receptor modulators for treating diabetes |
| 03/24/2010 | CN101678034A methods for treating neovascular ocular diseases |
| 03/24/2010 | CN101678033A Treprostinil treatment for interstitial lung disease and asthma |
| 03/24/2010 | CN101678032A compositions and methods for modulating inflammation using fluoroquinolones |
| 03/24/2010 | CN101678031A Formulations containing triazinones and iron |
| 03/24/2010 | CN101678030A Use of riboflavin in the treatment of hypertension |
| 03/24/2010 | CN101678029A Combination of a purine-based CDK inhibitor with a tyrosine kinase inhibitor and use thereof in the treatment of proliferative disorders |
| 03/24/2010 | CN101678028A Penciclovir for the treatment of recurrent genital herpes with a one-day application |
| 03/24/2010 | CN101678027A Pharmaceutical compositions for the treatment of chronic heart failure comprising pyrazolopyrimidinone derivative compound |
| 03/24/2010 | CN101678026A 3, 6-disubstituted-imidazo [1, 2-B] pyridazines and 3, 5-disubstituted pyrazolo[1, 5-A] pyrimidines as phosphatidylinositol-3-kinase inhibitors |
| 03/24/2010 | CN101678025A Tetrahydrobiopterin compositions, and methods of measuring |
| 03/24/2010 | CN101678024A Buspirone for the treatment of nausea and vomiting |
| 03/24/2010 | CN101678023A stabilized amorphous forms of imatinib mesylate |
| 03/24/2010 | CN101678022A 5-cyan0-4- (pyrrolo [2, 3b] pyridine-3-yl) -pyrimidine derivatives useful as protein kinase inhibitors |
| 03/24/2010 | CN101678021A Anti-cancer medicine both for diagnosing and treating cancer |
| 03/24/2010 | CN101678020A Quinoxaline derivatives as inhibitors of the tyrosine kinase activity of Janus kinases |
| 03/24/2010 | CN101678019A piperidine/piperazine derivatives |
| 03/24/2010 | CN101678018A (thio) -carbamoyl-cyclohexane derivatives and method for treating schizophrenia |
| 03/24/2010 | CN101678017A Method of treating diabetes |
| 03/24/2010 | CN101678016A N-oxides of 4,5-epoxy-morphinanium analogs |
| 03/24/2010 | CN101678015A Pyrrolo (3, 2, 1-ij) quinoline-4-one derivatives for treating tuberculosis |
| 03/24/2010 | CN101678014A 杂环激酶调节剂 Heterocycle kinase modulators |
| 03/24/2010 | CN101678013A piperidine/piperazine derivatives |
| 03/24/2010 | CN101678012A An allergen dosage form comprising an antihistamine |
| 03/24/2010 | CN101678011A Spiroindalones |
| 03/24/2010 | CN101678010A A composition comprising (r)-spiro[l- azabicyclo[2.2.2]octane-3,2'(3'h) -furo[2,3 -b]pyridine (azd0328) and its use in the treatment of alzheimer's disease, adhd or cognitive dysfunction |
| 03/24/2010 | CN101678009A Indolizine acetic acid derivatives as CRTH2 antagonists |
| 03/24/2010 | CN101678008A Anti-tumor activity of temsirolimus in papillary renal cell cancer |
| 03/24/2010 | CN101678007A gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 03/24/2010 | CN101678006A Prophylactic or therapeutic agent for posterior ocular disease comprising non-ergot selective d2 receptor agonist as active ingredient |
| 03/24/2010 | CN101678005A Combination of a muscarinic receptor antagonist and a beta-2-adrenoceptor agonist |
| 03/24/2010 | CN101678004A Triazol compounds for treating biofilm formation |
| 03/24/2010 | CN101678003A Use of biotin to prevent photoaging |
| 03/24/2010 | CN101678002A Methods of treatment using intravenous formulations comprising temozolomide |
| 03/24/2010 | CN101678001A Combination therapy comprising AZD2171 and AZD6244 or MEK-inhibitor II |
| 03/24/2010 | CN101678000A Use of 4-phenyl-imidazole-2-thiones as tyrosinase inhibitors for preparing pharmaceutical or cosmetic compositions for treating or preventing pigment disorders |
| 03/24/2010 | CN101677999A Methods for preserving renal function using xanthine oxidoreductase inhibitors |
| 03/24/2010 | CN101677998A a medicament for treating schizophrenia comprising cilostazol |
| 03/24/2010 | CN101677997A Kappa-opiate agonists for the treatment of diarrhea-predominant and alternating irritable bowel syndrome |
| 03/24/2010 | CN101677996A Ischemia/reperfusion protection compositions and methods of using |
| 03/24/2010 | CN101677995A Use of hdac inhibitors for the treatment of melanoma |
| 03/24/2010 | CN101677994A Melatonin tablet and methods of preparation and use |